Lunai Bioworks Financials - Benzinga

Lunai Bioworks Inc

LNAINASDAQ

Trade with Public

Trade with Public

$2.37

0.020.85%

At close: Aug 28, 5:00 PM EST

$2.50

0.135.49%

After Hours: Aug 27, 9:05 AM EST

Overview News Earnings ForecastFinancialsSentiment Compare Options Stock Report

Lunai Bioworks Financials

Lunai Bioworks (LNAI) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Lunai Bioworks Inc. - Common Stock Q3 EPS $(0.10), Sales $20.942K

Lunai Bioworks Inc. - Common Stock (NASDAQ:LNAI) reported quarterly losses of $(0.10) per share. The company reported $20.942 thousand in sales this quarter.

Benzinga Newsdesk

Stock Market Today: Nasdaq, S&P 500 Futures Gain While Dow Slips Amid Israel-Lebanon Ceasefire Extension—Intel, SAP, Lunai Bioworks In Focus (UPDATED)

(Editor’s note: The futures and ETFs data and headline were updated.) U.S. stock futures were mixed on Friday following Thursday's decline, after President Donald Trump announced the extension of the ceasefire between Israel and Lebanon by three weeks.

Benzinga Neuro

PRO
Lunai Bioworks Inc. - Common Stock Q2 EPS $(0.08) Up From $(0.45) YoY

Lunai Bioworks Inc. - Common Stock (NASDAQ:LNAI) reported quarterly losses of $(0.08) per share. This is a 82.22 percent increase over losses of $(0.45) per share from the same period last year.

Benzinga Newsdesk